Harmony Biosciences Holdings Inc (HRMY)

Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	21.31%261.28	215.39	243.78	239.46	200.49
Cost Of Revenue	41.98%63.20	44.51	68.55	59.65	38.15
Gross Profit	15.92%198.08	170.88	175.23	179.81	162.34
	18.58%108.77	133.58	136.67	114.32	114.16
Research and Development	32.84%46.60	69.38	49.93	54.96	50.16
Operating Income/Loss	139.51%89.32	37.29	38.56	65.49	48.18
Income/Loss From Continuing Operations Before Tax	135.00%93.27	39.69	40.76	67.49	49.64
Income Tax Expense/Benefit	147.73%17.83	7.20	18.27	16.63	9.86
	132.18%75.43	32.49	22.49	50.87	39.78
Attributable To Parent	132.18%75.43	32.49	22.49	50.87	39.78
Basic Average Shares	0.20%57.93	57.82	-0.16	57.55	57.47
Diluted Average Shares	0.04%58.76	58.78	-0.19	58.72	58.43
Basic Earnings Per Share	132.14%1.30	0.56	0.40	0.88	0.69
Diluted Earnings Per Share	132.73%1.28	0.55	0.39	0.87	0.68